Stem cells and progenitors in many lineages undergo self-renewing divisions, but the extracellular and intracellular proteins that regulate this process are largely unknown. Glucocorticoids stimulate red blood cell formation by promoting self-renewal of early burstforming unit-erythroid (BFU-E) progenitors [1] [2] [3] [4] . Here we show that the RNA-binding protein ZFP36L2 is a transcriptional target of the glucocorticoid receptor (GR) in BFU-Es and is required for BFU-E self-renewal. ZFP36L2 is normally downregulated during erythroid differentiation from the BFU-E stage, but its expression is maintained by all tested GR agonists that stimulate BFU-E selfrenewal, and the GR binds to several potential enhancer regions of ZFP36L2. Knockdown of ZFP36L2 in cultured BFU-E cells did not affect the rate of cell division but disrupted glucocorticoid-induced BFU-E self-renewal, and knockdown of ZFP36L2 in transplanted erythroid progenitors prevented expansion of erythroid lineage progenitors normally seen following induction of anaemia by phenylhydrazine treatment. ZFP36L2 preferentially binds to messenger RNAs that are induced or maintained at high expression levels during terminal erythroid differentiation and negatively regulates their expression levels. ZFP36L2 therefore functions as part of a molecular switch promoting BFU-E self-renewal and a subsequent increase in the total numbers of colony-forming unit-erythroid (CFU-E) progenitors and erythroid cells that are generated.
Stem cells and progenitors in many lineages undergo self-renewing divisions, but the extracellular and intracellular proteins that regulate this process are largely unknown. Glucocorticoids stimulate red blood cell formation by promoting self-renewal of early burstforming unit-erythroid (BFU-E) progenitors [1] [2] [3] [4] . Here we show that the RNA-binding protein ZFP36L2 is a transcriptional target of the glucocorticoid receptor (GR) in BFU-Es and is required for BFU-E self-renewal. ZFP36L2 is normally downregulated during erythroid differentiation from the BFU-E stage, but its expression is maintained by all tested GR agonists that stimulate BFU-E selfrenewal, and the GR binds to several potential enhancer regions of ZFP36L2. Knockdown of ZFP36L2 in cultured BFU-E cells did not affect the rate of cell division but disrupted glucocorticoid-induced BFU-E self-renewal, and knockdown of ZFP36L2 in transplanted erythroid progenitors prevented expansion of erythroid lineage progenitors normally seen following induction of anaemia by phenylhydrazine treatment. ZFP36L2 preferentially binds to messenger RNAs that are induced or maintained at high expression levels during terminal erythroid differentiation and negatively regulates their expression levels. ZFP36L2 therefore functions as part of a molecular switch promoting BFU-E self-renewal and a subsequent increase in the total numbers of colony-forming unit-erythroid (CFU-E) progenitors and erythroid cells that are generated.
Humans generate 10 11 erythrocytes every day, a process regulated by multiple hormones affecting several types of progenitors. Apoptosis, proliferation and terminal differentiation of CFU-E erythroid progenitors are mainly controlled by erythropoietin (EPO) 5, 6 . In contrast, many hormones including EPO, stem cell factor (SCF), interleukin-3 (IL-3) and interleukin-6 (IL-6) regulate the earlier BFU-E progenitors, but we do not know how they interact to control BFU-E quiescence, self-renewal divisions or cell divisions yielding the later CFU-E progenitors. Under stress conditions such as acute blood loss or chronic anaemia, glucocorticoids trigger self-renewal of BFU-E progenitors in the spleen, leading to increased numbers of self-renewal divisions. This results in increased BFU-E numbers and, over time, formation of increased numbers of CFU-E progenitors and subsequently of mature erythrocytes [1] [2] [3] [4] 7, 8 . To identify GR-activated genes essential for BFU-E self-renewal, BFU-Es were purified 1 and cultured in a medium (self-renewal medium) containing SCF, EPO, insulin-like growth factor 1 (IGF-1), and several full or dissociated GR agonists. All agonists, except for one dissociated agonist, stimulate BFU-E self-renewal ( Supplementary Fig. 1 ). Because the genes upregulated by all functional agonists represent candidates indispensable for BFU-E self-renewal, we performed deep sequencing on mRNAs from BFU-Es cultured with GR agonists for 4 h, and identified a group of genes upregulated by all functional agonists but not by nonfunctional agonists (Supplementary Table 1 ). We focused on three genes normally downregulated during erythroid differentiation, Zfp36l2, Hopx and Nlrp6 ( Supplementary Fig. 2, b, c) . As detailed later, knockdown of Hopx and Nlrp6 resulted in a defect in BFU-E proliferation. In contrast, knockdown of Zfp36l2, the most abundant transcript upregulated by GR agonists, did not affect the initial rate of BFU-E division.
During erythroid differentiation in vivo, ZFP36L2 is downregulated from the BFU-E stage (Fig. 1a, b) . BFU-Es cultured in vitro for 4 h with all functional GR agonists showed a ,2.5-fold upregulation of ZFP36L2 that was maintained throughout the culture (Fig. 1c-e) . Given that ZFP36L2 is upregulated after only 4 h, ZFP36L2 is likely a direct transcriptional target of the GR. Thus we performed GR chromatin immunoprecipitation sequencing (ChIP-seq) on freshly isolated BFU-Es after 1 h stimulation with dexamethasone (DEX) and identified five GR binding sites near the Zfp36l2 transcription start site (TSS), potential enhancers of Zfp36l2 (Supplementary Fig. 3 ). Four of these sites responded to DEX, indicating that they are functional enhancers regulated by glucocorticoids (Fig. 1g) . Together, these results indicate that ZFP36L2 is a direct transcriptional target of the GR in BFU-Es.
ZFP36L2 belongs to an RNA-binding protein family 9 . On the basis of RNA-seq gene expression data from purified BFU-E, CFU-E and Ter119-positive (Ter119
1
, also known as LY76) erythroblasts 1 , ZFP36L2 is ,20 times more abundant in erythroid progenitors than its other two family members, ZFP36 and ZFP36L1, and is the only member upregulated by DEX ( Fig. 1f and Supplementary Fig. 4 ), indicating that ZFP36L2 is the major family member involved in regulation of BFU-E self-renewal. Furthermore, ZFP36L2 is gradually downregulated from the haematopoietic stem cell (HSC) to the early and late erythroid progenitor stages ( Supplementary Fig. 5 ). In summary, glucocorticoid treatment of BFU-Es reverses normal downregulation of ZFP36L2, correlating with glucocorticoid-induced BFU-E self-renewal.
To test whether upregulation of ZFP36L2 is required for glucocorticoidinduced BFU-E self-renewal, we used two short hairpin RNAs (shRNAs) to knock down expression of ZFP36L2 in BFU-Es (Fig. 2a, b) . BFU-Es cultured without DEX stop proliferating at 4 days; as shown previously 1 , in the absence of DEX, each BFU-E generates several CFU-Es, each of which generates 10-30 erythroid cells over a 5 to 6 day period. In contrast, BFU-Es cultured in the presence of DEX continue to proliferate and generate over 10 times more mature erythroid cells at 9 days of culture. As shown previously 1 , in the presence of DEX, each BFU-E generates multiple daughter BFU-Es during the first days of culture; over time these BFU-Es generate increased numbers of daughter CFU-Es, each of which generates 10-30 erythroid cells. Importantly, BFU-Es expressing either Zfp36l2 shRNA stop proliferating at day 4, whether or not DEX is included; the proliferation kinetics are similar to those of BFU-Es cultured without DEX (Fig. 2c) . This indicates that knockdown of ZFP36L2 disrupts DEX-induced self-renewal of BFU-Es.
As one control, knockdown of c-Kit, a cell surface receptor required for the survival of haematopoietic stem and progenitor cells including BFU-Es, resulted in a blockage of BFU-E proliferation after only 1 day of culture (Supplementary Fig. 2a ). HOPX and NLRP6 share similar expression patterns as ZFP36L2, are downregulated during erythroid differentiation from the BFU-E stage and upregulated by DEX, and possess promoter regions that, based on our GR ChIP-Seq data, are occupied by GR. Knockdown of these also resulted in a blockage of BFU-E proliferation after only 1 day of culture ( Supplementary  Fig. 2b, c) .
To establish that ZFP36L2 is specifically required for BFU-E selfrenewal, 3-day BFU-E cultures were tested for their number of daughter BFU-Es by colony assays. Knockdown of ZFP36L2 significantly decreased the number of BFU-Es formed in the presence of DEX (Fig. 2d) . Knockdown of ZFP36L2 had no influence on apoptosis of BFU-Es (Fig. 2e) and, as expected on basis of its low level of expression in CFU-Es, knockdown of ZFP36L2 had no effect on erythroid differentiation beyond the CFU-E stage ( Supplementary Fig. 6 ). These data indicate that ZFP36L2 is specifically required for glucocorticoidinduced BFU-E self-renewal.
Glucocorticoids and GR are required for erythroid lineage cell expansion in the spleen during stress erythropoiesis 2, 4 . The data in Fig. 3 , using a phenylhydrazine (PHZ)-induced haemolytic anaemia mouse model, shows that ZFP36L2 is required for stress-induced erythroid lineage expansion in vivo. Lineage-negative (Lin 2 ) cells were isolated and infected with viruses encoding green fluorescence protein (GFP) and either a control shRNA or Zfp36l2 shRNAs, and then transplanted into lethally irradiated recipient mice. Six to eight weeks after transplantation, PHZ or control phosphate buffered saline (PBS) was injected intraperitoneally into transplanted mice at days 0 and 1 to induce haemolytic anaemia and erythroid lineage expansion. On day 4, spleens were dissected for flow cytometry analysis for multiple haematopoietic cells, detected by lineage specific markers (Fig. 3a) . Zfp36l2 shRNAs effectively knocked down the expression of ZFP36L2 in the Lin 2 cells ( Supplementary Fig. 7a ), and as expected, injection of PHZ resulted in a ,10-fold increase in systemic glucocorticoid levels (Fig. 3b) .
In control mice transplanted with Lin 2 cells infected with control shRNA, the majority of control transplanted GFP 1 splenic cells were 
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In vitro culture days Fig. 9a ). Importantly, knockdown of ZFP36L2 significantly impaired this erythroid lineage expansion (Fig. 3c) . In addition, the effects of ZFP36L2 in mediating haemolysis-induced cell expansion is specific to the erythroid lineage, as no other haematopoietic lineages showed a difference in the number of donor-derived GFP 1 cells between PBS and PHZ injection groups, with or without ZFP36L2 knockdown ( Fig. 3d and Supplementary Figs 10a, b and 11d-f) . Consistent with the increase in the percentage of Ter119 1 erythroid lineage cells in control mice upon PHZ injection, the percentages of other haematopoietic lineages were decreased upon PHZ injection, and these decreases were eliminated in the absence of ZFP36L2 (Supplementary Figs 9a-d and 11a-c) .
ZFP36L2 homozygous knockout mice die from HSC failure within 2 weeks after birth 10 , Supplementary Fig. 7b, c) .
Importantly, in mice transplanted with Lin 2 cells expressing the control shRNA the percentage of GFP 1 cells in the spleen does not significantly change after PHZ treatment, whereas in mice transplanted with Lin 2 cells infected with viruses encoding Zfp36l2 shRNAs, the percentage markedly drops following PHZ treatment (Supplementary Fig. 7d) , consistent with the loss of erythroid cell expansion (Fig. 3c) . Together, these data indicate that ZFP36L2 is specifically required for erythroid expansion during stress erythropoiesis in vivo and is consistent with the notion that it is essential for glucocorticoidinduced BFU-E self-renewal.
The data in Fig. 4 show that ZFP36L2 contributes to BFU-E selfrenewal by repressing expression of genes important for terminal erythroid differentiation. BFU-Es were cultured in self-renewal medium with or without DEX. At day 4, approximately 12% of the cells generated from BFU-Es cultured with DEX differentiated into Ter119 . P values were calculated using the two-tailed t-test. b, Microarrays were performed on BFU-Es infected with viruses encoding indicated shRNAs and cultured for 3 days in self-renewal medium with or without DEX. The x axis represents the relative expression of each gene calculated as a log 2 ratio of its expression in the indicated samples. The cumulative fraction (y axis) is plotted as a function of the relative expression (x axis). 'All genes' includes all of the genes in the microarray; 'Induced genes' represent a group of 340 genes most highly induced during erythroid differentiation from the CFU-E to the Ter119 1 erythroblast stage. P values were calculated using the KolmogorovSmirnov test. c, Genes that are downregulated by at least 20% in the presence of DEX and the subset of these genes that are upregulated by at least 20% upon knockdown of ZFP36L2 are shown through the same microarrays as those shown in b. d, The x axis represents the relative expression of each gene calculated as a log 2 ratio of its expression in CFU-Es relative to BFU-Es. The cumulative fraction (y axis) is plotted as a function of the relative expression (x axis). 'Targets' are the 2,000 microarray probes corresponding to mRNAs most preferentially found in the ZFP36L2 immunoprecipitate from the RIPchip assay. 'Non-targets' represent all remaining genes. P value was calculated using the Kolmogorov-Smirnov test.
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DEX became Ter119
1 , consistent with a DEX-triggered delay in terminal erythroid differentiation. This DEX-induced differentiation delay was eliminated by ZFP36L2 knockdown; loss of ZFP36L2 results in formation of ,30% Ter119 1 cells, similar to the percentage in cultures without DEX (Fig. 4a) , indicating that ZFP36L2 is essential for the glucocorticoid-induced delay of erythroid differentiation from the BFU-E stage. Consistent with a differentiation delay evidenced by the Ter119 marker, DEX treatment globally repressed the expression of a group of genes most highly induced during erythroid differentiation, and knockdown of ZFP36L2 eliminated this repression (Fig. 4b) .
This conclusion is further strengthened by experiments showing that overexpression of ZFP36L2 in BFU-Es significantly reduces the rate of cell proliferation ( Supplementary Fig. 12a, b) , but also delays erythroid differentiation. When cultured 4 days in the absence of DEX, the fraction of differentiated Ter119 1 cells was significantly lower in the overexpression cells than in the controls, and was similar to that from control BFU-Es cultured with DEX ( Supplementary Fig. 12c ). Although overexpression of ZFP36L2 led to a delay in erythroid differentiation, overexpression of ZFP36L2 in BFU-Es cultured without DEX was not able to rescue the self-renewal divisions, indicating that ZFP36L2 contributes to BFU-E self-renewal by delaying erythroid differentiation ( Supplementary Fig. 12b ).
To identify mRNAs in BFU-Es that directly bind to ZFP36L2, we performed an RNA-binding protein immunoprecipitation, using a verified ZFP36L2-specific antibody ( Supplementary Fig. 13a, b) , coupled to a microarray (RIP-chip) assay and identified many genes specifically immunoprecipitated by the ZFP36L2 antibody (Supplementary Table 2 ). Using this unbiased genomic approach, we showed that mRNAs containing AU-rich elements in their 39 untranslated regions (UTRs) are preferentially incorporated into the anti-ZFP36L2 immunoprecipitate ( Supplementary Fig. 14) ; ,72% of these mRNAs indeed contain the core ZFP36L2 recognition motif ATTTA element in their 39UTRs. This is consistent with previous reports concerning the binding specificity of ZFP36L2 11, 12 , but we cannot eliminate the possibility that some mRNAs are binding to other unknown proteins in complexes with ZFP36L2. Strikingly, we found that in BFU-Es, ZFP36L2 preferentially binds to mRNAs that tend to be induced or maintained at higher than average expression levels during subsequent erythroid differentiation to the CFU-E stage (Fig. 4d) . In addition, we found that the number of AU-rich elements of mRNAs bound by ZFP36L2 positively correlates with their extent of induction during erythroid differentiation from the BFU-E to CFU-E stage ( Supplementary Fig. 15a, b) . Thus, the expression pattern of ZFP36L2 negatively correlates with the expression pattern of erythroid differentiation-induced genes.
To globally identify functional targets whose expression levels are regulated by ZFP36L2, we analysed the gene expression profile of day 3 in vitro cultured BFU-Es with microarrays, allowing us to identify several genes with lower expression levels in BFU-Es cultured with DEX, compared with their counterparts in BFU-Es cultured without DEX (Fig. 4c) . Repression of several of these DEX-repressed genes is dependent on and presumably mediated by ZFP36L2, because knockdown of ZFP36L2 eliminated this repression (Fig. 4c) . A group of potential ZFP36L2 functional target genes was then identified by intersecting the set of these repressed genes with the group of genes identified by RIP-chip assay ( Supplementary Fig. 16 and Supplementary 
20
. We performed luciferase reporter assays on selected candidates, and found that the 39UTRs of many of these genes are ZFP36L2 responsive (Supplementary Table 4 ). In addition, we mutated AU-rich elements in the 39UTR of Aff1 and observed a statistically significant 21% increase (P 5 0.015) of luciferase activity, indicating that AU-rich elements are required for this regulation.
These data illustrate that ZFP36L2 globally negatively regulates the expression of several erythroid differentiation-induced genes, among which some are known to be required for erythroid differentiation and others are unknown but induced. Regulation by ZFP36L2 seems similar to microRNA-mediated post-transcriptional regulation. An individual microRNA binds to multiple target mRNAs and downregulates their expression levels often by only 20-50%; collectively, however, these modulations can have important biological effects. ZFP36L2 is normally downregulated during erythroid differentiation from the BFU-E stage, thus stabilizing many mRNAs required for terminal differentiation. ZFP36L2 transcription is enhanced by glucocorticoids under stress conditions that signal erythroid lineage cell expansion. Upregulation of ZFP36L2 in turn negatively regulates multiple differentiation-induced genes, causing a delay in erythroid differentiation and ultimately contributing to BFU-E self-renewal ( Supplementary Fig. 17 ). Altogether, our experiments uncover a novel mechanism that facilitates progenitor self-renewal: delaying differentiation by post-transcriptional downregulation of expression of mRNAs critical for progression to the next differentiation stage.
METHODS SUMMARY
BFU-Es were isolated from embryonic day 14.5 (E14.5) mouse fetal liver 1 , infected with viruses encoding GFP and either control shRNA or Zfp36l2 shRNAs, and cultured in self-renewal medium containing SCF, EPO and IGF-1 with or without DEX, and the cell numbers were counted daily throughout the in vitro culture. Lin 2 cells were isolated from mouse E14.5 fetal liver and infected with viruses encoding GFP and either control shRNA or Zfp36l2 shRNAs and transplanted into lethally irradiated recipient mice. Six to eight weeks after transplantation, the recipient mice were intraperitoneally injected with 60 mg per kg PHZ on day 0 and day 1. On day 4, spleens were dissected and measured for multiple types of GFP 1 haematopoietic cells, detected by the haematopoietic lineage specific markers.
METHODS
Primary BFU-Es and CFU-Es purification, retrovirus infection and in vitro culture. Primary BFU-Es and CFU-Es were purified from mouse E14.5 fetal liver 1 . BFU-Es were then placed in virus solution in a six-well plate, followed by 37 uC overnight incubation. After incubation, virus solution was substituted by a medium (self-renewal medium) containing SCF (100 ng ml 21 ), EPO (2 U ml 21 ) and IGF-1 (40 ng ml 21 ) with or without full and partial GR agonists. The cells were then in vitro cultured at 37 uC for 9 days.
For CFU-E differentiation assay, CFU-Es were placed in virus solution, followed by 37 uC spin infection. After infection, virus solution was substituted by an EPO containing differentiation medium, and the cells were then in vitro cultured for 2 days 21 . Cell number counting assay and BFU-E colony formation assay. In the BFU-E culture system, after infection with viruses encoding GFP and either control shRNA or Zfp36l2 shRNAs, the absolute numbers of GFP 1 cells were counted daily by flow cytometry, where the counting beads were used as an internal counting standard. For BFU-E colony formation assay, after 3 days culture, GFP 1 cells were sorted by flow cytometry and cultured in methylcellulose medium (MethoCult SF M3436 from StemCell Technologies), and the number of BFU-E colonies containing a cluster of more than 20 CFU-E colonies were counted 9 days after culture. In vivo PHZ induced haemolytic anaemia and bone marrow transplantation mouse model. Lin 2 cells were isolated from mouse E14.5 fetal liver and infected with viruses encoding GFP and either control shRNA or Zfp36l2 shRNAs and transplanted into lethally irradiated recipient mice. Six to eight weeks after transplantation, the recipient mice were intraperitoneally injected with 60 mg per kg PHZ or control PBS on day 0 and day 1. On day 4, spleens were dissected and measured for number and percentage of GFP 1 cells and of each type of GFP 1 haematopoietic lineage cell. Measurement of corticosterone level. Mice were injected with PHZ or PBS, and plasma were prepared 1 h after injection. Corticosterone levels were measured by using an ELISA kit according to instruction by the manufacturer Immunodiagnostic Systems. RIP-chip and data analysis. RIP-chip was carried out according to the instruction of EZ-Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore). BFU-Es were lysed and incubated with ZFP36L2 antibody (Abcam ab70775; 5 mg) or control IgG (5 mg) conjugated with magnetic beads (50 ml) for 4 h. The beads, protein and mRNA complexes were immunoprecipitated and magnetically separated. The mRNAs were purified and analysed by microarray (Affymetrix mouse gene 1.0 ST array). Ratios of each microarray probe between its intensity in ZFP36L2 antibody immunoprecipitated sample and its intensity in IgG-immunoprecipitated sample were calculated.
For the AU-rich element enrichment analysis, the 2,000 microarray probes corresponding to the mRNAs most preferentially bound by ZFP36L2 antibody are listed as 'Targets'. The 2,000 microarray probes corresponding to the mRNAs most preferentially bound by control IgG are listed as 'Non-targets'. The percentages of targets and non-targets containing indicated AU-rich elements in their 39UTR were calculated.
For the cumulative distribution plot, 'Targets' represents the 2,000 microarray probes corresponding to the mRNAs most preferentially bound by ZFP36L2 antibody in RIP-chip experiment. 'Non-targets' represents all remaining genes. The relative expressions of each gene calculated as a log 2 ratio between its intensity in CFU-E and its intensity in BFU-E 1 were calculated (x axis). The cumulative fraction is plotted as a function of the relative expression (y axis).
For the correlation analysis, the 2,000 transcripts that are most preferentially found in the ZFP36L2 immunoprecipitate in the RIP-chip experiments were ranked based on their relative expression levels calculated as a ratio of their expression levels in CFU-Es relative to BFU-Es, and were classified into 8 groups each with 250 transcripts based on their relative expression level ranking. One-way analysis of variance (ANOVA) analysis was performed to test the statistical significance of the difference among the average numbers of ATTTA elements in the 39UTR of each gene of these 8 groups by using GraphPad software. Test for linear trend after ANOVA was performed to test the statistical significance of the linear trend, the systematic increase of the average number of ATTTA elements in the 39UTR of each gene of these 8 groups as the rank of average relative expression levels of these 8 group increases, using GraphPad software. The average number of ATTTA elements in the 39UTR of each gene was plotted together with the average relative expression levels of each group for these 8 groups. The percentage of genes with ATTTA elements in their 39UTRs was plotted together with the average relative expression levels of each group for these 8 groups. The linear trend lines were drawn and the P values and r 2 values of the Pearson correlation test were calculated for these two plots.
